US Exocrine Pancreatic Insufficiency Market Set to Reach US$ 3.44 Billion by 2034 Amid Rising GI Disorder Cases
Exocrine pancreatic insufficiency (EPI) is a chronic condition characterized by the pancreas's inability to produce sufficient digestive enzymes, leading to malabsorption and nutritional deficiencies. The condition is commonly associated with diseases such as chronic pancreatitis, cystic fibrosis, and pancreatic cancer. Global Exocrine Pancreatic Insufficiency Industry Size and Growth...
0 Σχόλια 0 Μοιράστηκε 153 Views